Pharmacological Insights into Melasma: Understanding and Evaluating Treatment Modalities

Melasma, a complex pigmentary disorder, is characterized by the development of brown patches on sun-exposed areas of the face.Treatment for this intriguing dermatological condition has evolved over a century, with significant contributions to our understanding of its diagnosis, pathogenesis, and histology.Early classifications, groundbreaking theories, and advancements in the mid-20th century laid the groundwork for exploring the etiopathogenesis of melasma.From genetic predisposition and cutaneous vasculature to hormonal influences and UV radiation, this disorder's multifaceted nature is examined in this study from a pharmacological perspective.Treatment modalities, such as hydroquinone and tranexamic acid, are explored, emphasizing their pharmacological mechanisms and considerations.In conclusion, melasma's complexity demands a holistic approach, integrating pharmacological interventions for comprehensive management.